Brief: Active Biotech Q1 Operating Loss Narrows To SEK 6.4 Mln
April 25 (Reuters) - Active Biotech AB ACTI.ST :
* REG-ACTIVE BIOTECH AB - INTERIM REPORT JANUARY - MARCH
2019
* Q1 NET SALES SEK 5.5 MILLION VERSUS SEK 4.8 MILLION YEAR
AGO
* Q1 OPERATING LOSS SEK 6.4 MILLION VERSUS LOSS SEK 8.5
MILLION
YEAR AGO
Source text for Eikon: ID:nGNE3hJ5DH
Further company coverage: ACTI.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Active Biotech AB publ
See all newsBrief: Active Biotech Says Japan Grants Patent For Laquinimod Ophthalmic Formulation
Brief: Active Biotech Reports Q2 Operating Profit Of SEK -10.2 Mln
Brief: Active Biotech Expands U.S. Collaboration
Brief: Active Biotech Gets Approval To Resume Enrolment In Hovon 172 MF Study
Brief: Active Biotech Q1 Loss After Tax At SEK 8.4 Million